adjuvant therapy to target the increased reliance on glycolytic promised patients [22]. However, these experiments also 3!
metabolism that is a hallmark of cancer [52]. Yef3 and its revealed something even more surprising: abundant biologi- =
paralogue Hef3 function as ribosomal elongation factors cal phenotypes with prion-like patterns of transmission that =
(eukaryotic EF3), controlling a translational response that is did not arise from any known prion protein. Here, we inves- = &
key to surviving oxidative stress [53,54]. Finally, Nop1 over- tigated the molecular origin of such phenotypes. Our =
expression has previously been reported to slow cell cycle findings suggest that S. cerevisiae may commonly employ =
progression [55] and vegetative growth [56]. In sum, our protein aggregation, some of it prion-like, as it adapts to s
combined biochemical and cell biological methodology suc- new environments [70-72], including human hosts. Ss
cessfully identified proteins that selectively aggregate in the Harbouring one prion can increase the likelihood of Ss
clinical S. cerevisiae isolates and appear connected to at least acquiring another [60-62] and several, such as [PSI*] and
some of the curable traits that they harbour. [RNQ*], commonly co-occur [22,73]. This combinatorial

interdependence, along with the fact that ‘curing’ eliminates
multiple prions, can complicate efforts to induce such aggre-

(d) Cdc19 aggregates are heritable across cell divisions gates in laboratory strains. Although we could easily observe
Our observation that assemblies formed by Yef3, Nop1 and amyloid conformers of relatively rare proteins such as Rnq1
Cdcl9 in clinical strains were permanently eliminated by tran- (approx. 1000 molecules per cell [74]), like all proteomic
sient exposure to guanidine hydrochloride suggested that they approaches, our method is fundamentally limited by a pro-
might have prion-like properties. However, these proteins do tein’s natural abundance. Obtaining high coverage will thus
not have any discernable N/Q-rich prion-like domains, and be required to identify prion proteins that are expressed at
only Nop! had a large disordered region [57] (electronic sup- low levels.
plementary material, figure S4). We, therefore, examined Cdcl9 has previously been shown to form reversible
their capacity to self-template experimentally. To do so, we aggregates in vivo, regulated in part by phosphorylation
used a seeding assay in which transient overexpression of the that, in turn, exerts cell cycle control [47]. In vitro, it forms